Sandoz Group AG ADR (D8Y0)

Overview

Sandoz Group AG is a global leader in the development, manufacture, and marketing of generic pharmaceuticals and biosimilars. Established in 1886, the company has its headquarters in Basel, Switzerland. Sandoz operates globally, offering a wide range of therapeutic solutions aimed at improving patient outcomes. Its mission revolves around making high-quality medicines accessible to people worldwide, leveraging its extensive experience and innovation in the pharmaceutical sector.

Products and Services

• Cardiovascular - Sandoz offers a comprehensive range of products for treating cardiovascular diseases, aiming to improve heart health and patient quality of life.
• Central Nervous System - The company provides generic treatments for central nervous system disorders, focusing on medications that help manage conditions such as epilepsy and multiple sclerosis.
• Oncology - Sandoz supports cancer treatment with generic drugs and biosimilars, designed to be more accessible options for patients undergoing oncologic therapies.
• Infectious Diseases - They have a broad portfolio of antibiotics and antiviral medicines to treat various infectious diseases, contributing to global efforts in combating antimicrobial resistance.
• Pain and Respiratory - The company develops medications for managing pain and respiratory conditions, helping individuals lead more comfortable lives.
• Diabetes - Sandoz provides treatments for diabetes, focusing on improving the lives of those living with this chronic condition through more affordable therapeutic options.
• Immunology, Endocrinology, Hematology - Products in these categories include treatments for autoimmune diseases, hormonal disorders, and blood conditions, addressing a range of complex health issues.
• Ophthalmology - Sandoz also offers treatments for eye diseases, supporting vision health and preventing blindness.
• Bone Disease - The company has treatments for bone diseases, focusing on medications that help improve bone density and reduce fracture risk.
• Active Pharmaceutical Ingredients and Finished Dosage Forms - Sandoz supplies a wide range of active ingredients and finished pharmaceutical products, catering to both the manufacturing needs of the industry and the direct treatment needs of patients.